PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"33378609","Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group.","N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.","Baden LR","N Engl J Med","2021","2020/12/30","PMC7787219","","10.1056/NEJMoa2035389"
"34812653","Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA; Immune Assays Team§; Moderna, Inc. Team§; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team§; United States Government (USG)/CoVPN Biostatistics Team§.","Science. 2022 Jan 7;375(6576):43-50. doi: 10.1126/science.abm3425. Epub 2021 Nov 23.","Gilbert PB","Science","2022","2021/11/23","PMC9017870","NIHMS1800809","10.1126/science.abm3425"
"34551225","Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase","El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group.","N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22.","El Sahly HM","N Engl J Med","2021","2021/09/22","PMC8482810","NIHMS1743941","10.1056/NEJMoa2113017"
"33761206","Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults","Gray GE, Bekker LG, Laher F, Malahleha M, Allen M, Moodie Z, Grunenberg N, Huang Y, Grove D, Prigmore B, Kee JJ, Benkeser D, Hural J, Innes C, Lazarus E, Meintjes G, Naicker N, Kalonji D, Nchabeleng M, Sebe M, Singh N, Kotze P, Kassim S, Dubula T, Naicker V, Brumskine W, Ncayiya CN, Ward AM, Garrett N, Kistnasami G, Gaffoor Z, Selepe P, Makhoba PB, Mathebula MP, Mda P, Adonis T, Mapetla KS, Modibedi B, Philip T, Kobane G, Bentley C, Ramirez S, Takuva S, Jones M, Sikhosana M, Atujuna M, Andrasik M, Hejazi NS, Puren A, Wiesner L, Phogat S, Diaz Granados C, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, McElrath MJ, Gilbert PB, Janes H, Corey L; HVTN 702 Study Team.","N Engl J Med. 2021 Mar 25;384(12):1089-1100. doi: 10.1056/NEJMoa2031499.","Gray GE","N Engl J Med","2021","2021/03/24","PMC7888373","","10.1056/NEJMoa2031499"
"33730454","Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams.","N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.","Corey L","N Engl J Med","2021","2021/03/17","PMC8189692","NIHMS1701559","10.1056/NEJMoa2031738"
"36001680","A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection","Murphy SC, Vaughan AM, Kublin JG, Fishbauger M, Seilie AM, Cruz KP, Mankowski T, Firat M, Magee S, Betz W, Kain H, Camargo N, Haile MT, Armstrong J, Fritzen E, Hertoghs N, Kumar S, Sather DN, Pinder LF, Deye GA, Galbiati S, Geber C, Butts J, Jackson LA, Kappe SHI.","Sci Transl Med. 2022 Aug 24;14(659):eabn9709. doi: 10.1126/scitranslmed.abn9709. Epub 2022 Aug 24.","Murphy SC","Sci Transl Med","2022","2022/08/24","","","10.1126/scitranslmed.abn9709"
"33010242","Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study","Baden LR, Stieh DJ, Sarnecki M, Walsh SR, Tomaras GD, Kublin JG, McElrath MJ, Alter G, Ferrari G, Montefiori D, Mann P, Nijs S, Callewaert K, Goepfert P, Edupuganti S, Karita E, Langedijk JP, Wegmann F, Corey L, Pau MG, Barouch DH, Schuitemaker H, Tomaka F; Traverse/HVTN 117/HPX2004 Study Team.","Lancet HIV. 2020 Oct;7(10):e688-e698. doi: 10.1016/S2352-3018(20)30229-0.","Baden LR","Lancet HIV","2020","2020/10/03","PMC7529856","","10.1016/S2352-3018(20)30229-0"
"36203582","Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials","Owalla TJ, Hergott DEB, Seilie AM, Staubus W, Chavtur C, Chang M, Kublin JG, Egwang TG, Murphy SC.","Front Immunol. 2022 Sep 20;13:1003452. doi: 10.3389/fimmu.2022.1003452. eCollection 2022.","Owalla TJ","Front Immunol","2022","2022/10/07","PMC9531235","","10.3389/fimmu.2022.1003452"
"35493113","COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective","Marcelin JR, Pettifor A, Janes H, Brown ER, Kublin JG, Stephenson KE.","Open Forum Infect Dis. 2022 Mar 10;9(5):ofac124. doi: 10.1093/ofid/ofac124. eCollection 2022 May.","Marcelin JR","Open Forum Infect Dis","2022","2022/05/02","PMC8992234","","10.1093/ofid/ofac124"
"36240834","Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel","Miner MD, Hatherill M, Mave V, Gray GE, Nachman S, Read SW, White RG, Hesseling A, Cobelens F, Patel S, Frick M, Bailey T, Seder R, Flynn J, Rengarajan J, Kaushal D, Hanekom W, Schmidt AC, Scriba TJ, Nemes E, Andersen-Nissen E, Landay A, Dorman SE, Aldrovandi G, Cranmer LM, Day CL, Garcia-Basteiro AL, Fiore-Gartland A, Mogg R, Kublin JG, Gupta A, Churchyard G.","Lancet HIV. 2022 Nov;9(11):e791-e800. doi: 10.1016/S2352-3018(22)00255-7. Epub 2022 Oct 11.","Miner MD","Lancet HIV","2022","2022/10/14","PMC9667733","NIHMS1843749","10.1016/S2352-3018(22)00255-7"
"25428938","Tuberculosis vaccines and prevention of infection","Hawn TR, Day TA, Scriba TJ, Hatherill M, Hanekom WA, Evans TG, Churchyard GJ, Kublin JG, Bekker LG, Self SG.","Microbiol Mol Biol Rev. 2014 Dec;78(4):650-71. doi: 10.1128/MMBR.00021-14.","Hawn TR","Microbiol Mol Biol Rev","2014","2014/11/28","PMC4248657","","10.1128/MMBR.00021-14"
"26827165","Selection of HIV vaccine candidates for concurrent testing in an efficacy trial","Huang Y, DiazGranados C, Janes H, Huang Y, deCamp AC, Metch B, Grant S, Sanchez B, Phogat S, Koutsoukos M, Kanesa-Thasan N, Bourguignon P, Collard A, Buchbinder S, Tomaras GD, McElrath J, Gray G, Kublin JG, Corey L, Gilbert PB.","Curr Opin Virol. 2016 Apr;17:57-65. doi: 10.1016/j.coviro.2016.01.007. Epub 2016 Jan 29.","Huang Y","Curr Opin Virol","2016","2016/02/01","PMC4902743","NIHMS756136","10.1016/j.coviro.2016.01.007"
"34002544","HIV vaccines beyond COVID-19: merits of trust","Kublin JG.","J Int AIDS Soc. 2021 May;24(5):e25742. doi: 10.1002/jia2.25742.","Kublin JG","J Int AIDS Soc","2021","2021/05/18","PMC8129633","","10.1002/jia2.25742"
"24033299","Lessons learned from HIV vaccine clinical efficacy trials","Day TA, Kublin JG.","Curr HIV Res. 2013 Sep;11(6):441-9. doi: 10.2174/1570162x113116660051.","Day TA","Curr HIV Res","2013","2013/09/17","PMC4000156","NIHMS538919","10.2174/1570162x113116660051"
"29176431","Utilizing gnotobiotic models to inform the role of the microbiome in vaccine response heterogeneity","Cram JA, Hager KW, Kublin JG.","Curr Opin HIV AIDS. 2018 Jan;13(1):1-8. doi: 10.1097/COH.0000000000000422.","Cram JA","Curr Opin HIV AIDS","2018","2017/11/28","","","10.1097/COH.0000000000000422"
"16323123","HIV infection and malaria--understanding the interactions","Kublin JG, Steketee RW.","J Infect Dis. 2006 Jan 1;193(1):1-3. doi: 10.1086/498581. Epub 2005 Nov 18.","Kublin JG","J Infect Dis","2006","2005/12/03","","","10.1086/498581"
"19050380","Post-step modifications for research on HIV vaccines","Corey L, McElrath MJ, Kublin JG.","AIDS. 2009 Jan 2;23(1):3-8. doi: 10.1097/QAD.0b013e32830e6d6d.","Corey L","AIDS","2009","2008/12/04","PMC2720076","NIHMS120251","10.1097/QAD.0b013e32830e6d6d"
"11756042","Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?","Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM.","Trends Parasitol. 2001 Dec;17(12):582-8. doi: 10.1016/s1471-4922(01)02085-2.","Sibley CH","Trends Parasitol","2001","2002/01/05","","","10.1016/s1471-4922(01)02085-2"
"36824851","The Regulation of Nucleic Acid Vaccine Responses by the Microbiome","Johnson AMF, Hager K, Alameh MG, Van P, Potchen N, Mayer-Blackwell K, Fiore-Gartland A, Minot S, Lin PJC, Tam YK, Weissman D, Kublin JG.","bioRxiv. 2023 Feb 19:2023.02.18.529093. doi: 10.1101/2023.02.18.529093. Preprint.","Johnson AMF","bioRxiv","2023","2023/02/24","PMC9949122","","10.1101/2023.02.18.529093"
"16323101","Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis","Walker M, Kublin JG, Zunt JR.","Clin Infect Dis. 2006 Jan 1;42(1):115-25. doi: 10.1086/498510. Epub 2005 Nov 23.","Walker M","Clin Infect Dis","2006","2005/12/03","PMC2683841","NIHMS109762","10.1086/498510"
"36658109","Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial","Fong Y, Huang Y, Benkeser D, Carpp LN, Áñez G, Woo W, McGarry A, Dunkle LM, Cho I, Houchens CR, Martins K, Jayashankar L, Castellino F, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Randhawa AK, Andrasik MP, Kublin JG, Hutter J, Keshtkar-Jahromi M, Beresnev TH, Corey L, Neuzil KM, Follmann D, Ake JA, Gay CL, Kotloff KL, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team; United States Government (USG)/CoVPN Biostatistics Team.","Nat Commun. 2023 Jan 19;14(1):331. doi: 10.1038/s41467-022-35768-3.","Fong Y","Nat Commun","2023","2023/01/19","PMC9851580","","10.1038/s41467-022-35768-3"
"36949083","Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial","Fong Y, Huang Y, Benkeser D, Carpp LN, Áñez G, Woo W, McGarry A, Dunkle LM, Cho I, Houchens CR, Martins K, Jayashankar L, Castellino F, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Randhawa AK, Andrasik MP, Kublin JG, Hutter J, Keshtkar-Jahromi M, Beresnev TH, Corey L, Neuzil KM, Follmann D, Ake JA, Gay CL, Kotloff KL, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team; United States Government (USG)/CoVPN Biostatistics Team.","Nat Commun. 2023 Mar 22;14(1):1581. doi: 10.1038/s41467-023-37367-2.","Fong Y","Nat Commun","2023","2023/03/23","PMC10031713","","10.1038/s41467-023-37367-2"
"36357712","Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial","Fong Y, McDermott AB, Benkeser D, Roels S, Stieh DJ, Vandebosch A, Le Gars M, Van Roey GA, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Hyrien O, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Little SJ, Paiva de Sousa L, Maboa R, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Carpp LN, Follmann D, Gilbert PB, Koup RA, Donis RO; Immune Assays Team; the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; and the United States Government (USG)/CoVPN Biostatistics Team.","Nat Microbiol. 2022 Dec;7(12):1996-2010. doi: 10.1038/s41564-022-01262-1. Epub 2022 Nov 10.","Fong Y","Nat Microbiol","2022","2022/11/10","PMC10166187","NIHMS1867012","10.1038/s41564-022-01262-1"
"17893303","Challenges in the prevention, diagnosis, and treatment of malaria in human immunodeficiency virus infected adults in sub-Saharan Africa","Brentlinger PE, Behrens CB, Kublin JG.","Arch Intern Med. 2007 Sep 24;167(17):1827-36. doi: 10.1001/archinte.167.17.1827.","Brentlinger PE","Arch Intern Med","2007","2007/09/26","","","10.1001/archinte.167.17.1827"
"36899062","Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine","Benkeser D, Fong Y, Janes HE, Kelly EJ, Hirsch I, Sproule S, Stanley AM, Maaske J, Villafana T, Houchens CR, Martins K, Jayashankar L, Castellino F, Ayala V, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Carpp LN, Randhawa AK, Andrasik MP, Kublin JG, Isaacs MB, Makhene M, Tong T, Robb ML, Corey L, Neuzil KM, Follmann D, Hoffman C, Falsey AR, Sobieszczyk M, Koup RA, Donis RO, Gilbert PB; AstraZeneca AZD1222 Clinical Study Group; Immune Assays Team; United States Government (USG)/CoVPN Biostatistics Team.","NPJ Vaccines. 2023 Mar 11;8(1):36. doi: 10.1038/s41541-023-00630-0.","Benkeser D","NPJ Vaccines","2023","2023/03/10","PMC10005913","","10.1038/s41541-023-00630-0"
"34401888","Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial","Gilbert PB, Montefiori DC, McDermott A, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi N, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Kutner M, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA.","medRxiv. 2021 Aug 15:2021.08.09.21261290. doi: 10.1101/2021.08.09.21261290. Preprint.","Gilbert PB","medRxiv","2021","2021/08/17","PMC8366808","","10.1101/2021.08.09.21261290"
"36311720","Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines","Mayer-Blackwell K, Johnson AM, Potchen N, Minot SS, Heptinstall J, Seaton K, Sawant S, Shen X, Tomaras GD, Fiore-Gartland A, Kublin JG.","Front Immunol. 2022 Oct 12;13:983313. doi: 10.3389/fimmu.2022.983313. eCollection 2022.","Mayer-Blackwell K","Front Immunol","2022","2022/10/31","PMC9597301","","10.3389/fimmu.2022.983313"
"28053159","Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects","Kublin JG, Mikolajczak SA, Sack BK, Fishbaugher ME, Seilie A, Shelton L, VonGoedert T, Firat M, Magee S, Fritzen E, Betz W, Kain HS, Dankwa DA, Steel RW, Vaughan AM, Noah Sather D, Murphy SC, Kappe SH.","Sci Transl Med. 2017 Jan 4;9(371):eaad9099. doi: 10.1126/scitranslmed.aad9099.","Kublin JG","Sci Transl Med","2017","2017/01/06","","","10.1126/scitranslmed.aad9099"
"35441174","Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial","Fong Y, McDermott AB, Benkeser D, Roels S, Stieh DJ, Vandebosch A, Gars ML, Van Roey GA, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Hyrien O, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Little SJ, de Sousa LP, Maboa R, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Carpp LN, Follmann D, Gilbert PB, Koup RA, Donis RO; Janssen Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team.","medRxiv. 2022 Apr 12:2022.04.06.22272763. doi: 10.1101/2022.04.06.22272763. Preprint.","Fong Y","medRxiv","2022","2022/04/20","PMC9016647","","10.1101/2022.04.06.22272763"
"37385888","Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials","Turley CB, Tables L, Fuller T, Sanders LJ, Scott H, Moodley A, Woodward Davis A, Leav B, Miller J, Schoemaker K, Vandebosch A, Sadoff J, Woo W, Cho I, Dunkle LM, Li S, van der Laan L, Gilbert PB, Follmann D, Jaynes H, Kublin JG, Baden LR, Goepfert P, Kotloff K, Gay CL, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Rouphael N, Luedtke A; COVID-19 Prevention Network CoVPN.","Vaccine. 2023 Jul 25;41(33):4899-4906. doi: 10.1016/j.vaccine.2023.06.066. Epub 2023 Jun 23.","Turley CB","Vaccine","2023","2023/06/29","PMC10288314","","10.1016/j.vaccine.2023.06.066"
"25454855","Use of placebos in Phase 1 preventive HIV vaccine clinical trials","Huang Y, Karuna ST, Janes H, Frahm N, Nason M, Edlefsen PT, Kublin JG, Corey L, McElrath MJ, Gilbert PB.","Vaccine. 2015 Feb 4;33(6):749-52. doi: 10.1016/j.vaccine.2014.10.017. Epub 2014 Oct 23.","Huang Y","Vaccine","2015","2014/12/03","PMC4554766","NIHMS715614","10.1016/j.vaccine.2014.10.017"
"36689221","Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials","Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah KA, Zhang Y, Gilbert P, Janes H, Gay CL, Falsey AR, Tripp RL, Gorman RL, Tong T, Marovich M, Neuzil K, Corey L, Kublin JG; COVID-19 Prevention Network.","JAMA Netw Open. 2023 Jan 3;6(1):e2251974. doi: 10.1001/jamanetworkopen.2022.51974.","Mena Lora AJ","JAMA Netw Open","2023","2023/01/23","","","10.1001/jamanetworkopen.2022.51974"
"33720973","Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk","Andersen-Nissen E, Fiore-Gartland A, Ballweber Fleming L, Carpp LN, Naidoo AF, Harper MS, Voillet V, Grunenberg N, Laher F, Innes C, Bekker LG, Kublin JG, Huang Y, Ferrari G, Tomaras GD, Gray G, Gilbert PB, McElrath MJ.","PLoS Pathog. 2021 Mar 15;17(3):e1009363. doi: 10.1371/journal.ppat.1009363. eCollection 2021 Mar.","Andersen-Nissen E","PLoS Pathog","2021","2021/03/15","PMC7959397","","10.1371/journal.ppat.1009363"
"31534016","Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa","Gray GE, Huang Y, Grunenberg N, Laher F, Roux S, Andersen-Nissen E, De Rosa SC, Flach B, Randhawa AK, Jensen R, Swann EM, Bekker LG, Innes C, Lazarus E, Morris L, Mkhize NN, Ferrari G, Montefiori DC, Shen X, Sawant S, Yates N, Hural J, Isaacs A, Phogat S, DiazGranados CA, Lee C, Sinangil F, Michael NL, Robb ML, Kublin JG, Gilbert PB, McElrath MJ, Tomaras GD, Corey L.","Sci Transl Med. 2019 Sep 18;11(510):eaax1880. doi: 10.1126/scitranslmed.aax1880.","Gray GE","Sci Transl Med","2019","2019/09/20","PMC7199879","NIHMS1054745","10.1126/scitranslmed.aax1880"
"37075127","Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial","Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Williamson BD, Garver J, Altonen E, Rudge T, Huynh C, Miller J, El Sahly HM, Baden LR, Frey S, Malkin E, Spector SA, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA, Gilbert PB; Immune Assays; Moderna Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); United States Government (USG)/CoVPN Biostatistics Teams.","Sci Transl Med. 2023 Apr 19;15(692):eade9078. doi: 10.1126/scitranslmed.ade9078. Epub 2023 Apr 19.","Benkeser D","Sci Transl Med","2023","2023/04/19","PMC10243212","NIHMS1899084","10.1126/scitranslmed.ade9078"
"31308962","Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa","Lazarus E, Otwombe K, Dietrich J, Andrasik MP, Morgan CA, Kublin JG, Gray GE, Isaacs AJ, Laher F.","South Afr J HIV Med. 2019 Jun 20;20(1):866. doi: 10.4102/sajhivmed.v20i1.866. eCollection 2019.","Lazarus E","South Afr J HIV Med","2019","2019/07/17","PMC6620501","","10.4102/sajhivmed.v20i1.866"
"33336213","Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials","Follmann D, Fintzi J, Fay MP, Janes HE, Baden L, Sahly HE, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM.","medRxiv. 2020 Dec 14:2020.12.14.20248137. doi: 10.1101/2020.12.14.20248137. Preprint.","Follmann D","medRxiv","2020","2020/12/18","PMC7745130","","10.1101/2020.12.14.20248137"
"28538691","The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States","Adamson BJS, Carlson JJ, Kublin JG, Garrison LP.","Vaccines (Basel). 2017 May 24;5(2):13. doi: 10.3390/vaccines5020013.","Adamson BJS","Vaccines (Basel)","2017","2017/05/25","PMC5492010","","10.3390/vaccines5020013"
"12803862","Retinal changes in adults with cerebral malaria","Beare NA, Lewis DK, Kublin JG, Harding SP, Zijlstra EE, Molyneux ME.","Ann Trop Med Parasitol. 2003 Apr;97(3):313-5. doi: 10.1179/000349803235001859.","Beare NA","Ann Trop Med Parasitol","2003","2003/06/14","","","10.1179/000349803235001859"
"32644127","Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study","Kublin JG, Murphy SC, Maenza J, Seilie AM, Jain JP, Berger D, Spera D, Zhao R, Soon RL, Czartoski JL, Potochnic MA, Duke E, Chang M, Vaughan A, Kappe SHI, Leong FJ, Pertel P, Prince WT; KAF156 Study Team.","Clin Infect Dis. 2021 Oct 5;73(7):e2407-e2414. doi: 10.1093/cid/ciaa952.","Kublin JG","Clin Infect Dis","2021","2020/07/10","PMC8678739","","10.1093/cid/ciaa952"
"23243491","HIV Vaccine Trials Network: activities and achievements of the first decade and beyond","Kublin JG, Morgan CA, Day TA, Gilbert PB, Self SG, McElrath MJ, Corey L.","Clin Investig (Lond). 2012 Mar;2(3):245-254. doi: 10.4155/cli.12.8.","Kublin JG","Clin Investig (Lond)","2012","2012/12/18","PMC3521567","NIHMS424857","10.4155/cli.12.8"
"24795481","HIV-1 infection and antibodies to Plasmodium falciparum in adults","Hasang W, Dembo EG, Wijesinghe R, Molyneux ME, Kublin JG, Rogerson S.","J Infect Dis. 2014 Nov 1;210(9):1407-14. doi: 10.1093/infdis/jiu262. Epub 2014 May 3.","Hasang W","J Infect Dis","2014","2014/05/06","","","10.1093/infdis/jiu262"
"9620719","Molecular assays for surveillance of antifolate-resistant malaria","Kublin JG, Witzig RS, Shankar AH, Zurita JQ, Gilman RH, Guarda JA, Cortese JF, Plowe CV.","Lancet. 1998 May 30;351(9116):1629-30. doi: 10.1016/S0140-6736(98)24022-0.","Kublin JG","Lancet","1998","1998/06/10","","","10.1016/S0140-6736(98)24022-0"
"25672905","Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi","Artimovich E, Schneider K, Taylor TE, Kublin JG, Dzinjalamala FK, Escalante AA, Plowe CV, Laufer MK, Takala-Harrison S.","J Infect Dis. 2015 Sep 1;212(5):694-701. doi: 10.1093/infdis/jiv078. Epub 2015 Feb 11.","Artimovich E","J Infect Dis","2015","2015/02/13","PMC4539899","","10.1093/infdis/jiv078"
"31869338","Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination","Cram JA, Fiore-Gartland AJ, Srinivasan S, Karuna S, Pantaleo G, Tomaras GD, Fredricks DN, Kublin JG.","PLoS One. 2019 Dec 23;14(12):e0225622. doi: 10.1371/journal.pone.0225622. eCollection 2019.","Cram JA","PLoS One","2019","2019/12/24","PMC6927600","","10.1371/journal.pone.0225622"
"33844575","A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated","Follmann D, Fintzi J, Fay MP, Janes HE, Baden LR, El Sahly HM, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM.","Ann Intern Med. 2021 Aug;174(8):1118-1125. doi: 10.7326/M20-8149. Epub 2021 Apr 13.","Follmann D","Ann Intern Med","2021","2021/04/12","PMC8099035","","10.7326/M20-8149"
"29594618","Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa","Dietrich JJ, Lazarus E, Andrasik M, Hornschuh S, Otwombe K, Morgan C, Isaacs AJ, Huang Y, Laher F, Kublin JG, Gray GE; HVTN 915 study team.","AIDS Behav. 2018 Jul;22(7):2312-2321. doi: 10.1007/s10461-018-2080-y.","Dietrich JJ","AIDS Behav","2018","2018/03/30","PMC6176864","NIHMS962370","10.1007/s10461-018-2080-y"
"28526032","Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs","Hanron AE, Billman ZP, Seilie AM, Olsen TM, Fishbaugher M, Chang M, Rueckle T, Andenmatten N, Greenhouse B, Arinaitwe E, Rek J, Das S, Domingo GJ, Shipman K, Kappe SH, Kublin JG, Murphy SC.","Malar J. 2017 May 19;16(1):208. doi: 10.1186/s12936-017-1863-3.","Hanron AE","Malar J","2017","2017/05/21","PMC5438523","","10.1186/s12936-017-1863-3"
"35758878","Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk","Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, Heptinstall J, Omar FL, Cohen K, De Rosa SC, Zhang L, Yates NL, Sarzotti-Kelsoe M, Seaton KE, Laher F, Bekker LG, Malahleha M, Innes C, Kassim S, Naicker N, Govender V, Sebe M, Singh N, Kotze P, Lazarus E, Nchabeleng M, Ward AM, Brumskine W, Dubula T, Randhawa AK, Grunenberg N, Hural J, Kee JJ, Benkeser D, Jin Y, Carpp LN, Allen M, D'Souza P, Tartaglia J, DiazGranados CA, Koutsoukos M, Gilbert PB, Kublin JG, Corey L, Andersen-Nissen E, Gray GE, Tomaras GD, McElrath MJ.","J Infect Dis. 2022 Aug 24;226(2):246-257. doi: 10.1093/infdis/jiac260.","Moodie Z","J Infect Dis","2022","2022/06/27","PMC9890908","","10.1093/infdis/jiac260"
"24029738","Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?","Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM Jr, Wasserheit JN.","AIDS. 2013 Sep 24;27(15):2494-6. doi: 10.1097/01.aids.0000432463.23508.a2.","Abu-Raddad LJ","AIDS","2013","2013/09/14","","","10.1097/01.aids.0000432463.23508.a2"
"26844286","Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models","Dimitrov D, Kublin JG, Ramsey S, Corey L.","EBioMedicine. 2015 Nov 5;2(12):2062-9. doi: 10.1016/j.ebiom.2015.11.009. eCollection 2015 Dec.","Dimitrov D","EBioMedicine","2015","2016/02/05","PMC4703729","","10.1016/j.ebiom.2015.11.009"
"31679015","Growth Rate of Plasmodium falciparum: Analysis of Parasite Growth Data From Malaria Volunteer Infection Studies","Wockner LF, Hoffmann I, Webb L, Mordmüller B, Murphy SC, Kublin JG, O'Rourke P, McCarthy JS, Marquart L.","J Infect Dis. 2020 Mar 2;221(6):963-972. doi: 10.1093/infdis/jiz557.","Wockner LF","J Infect Dis","2020","2019/11/04","PMC7198127","","10.1093/infdis/jiz557"
"29666455","Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study","de Montigny S, Adamson BJS, Mâsse BR, Garrison LP Jr, Kublin JG, Gilbert PB, Dimitrov DT.","Sci Rep. 2018 Apr 17;8(1):6066. doi: 10.1038/s41598-018-24268-4.","de Montigny S","Sci Rep","2018","2018/04/19","PMC5904131","","10.1038/s41598-018-24268-4"
"31621832","Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults","Healy SA, Murphy SC, Hume JCC, Shelton L, Kuntz S, Van Voorhis WC, Moodie Z, Metch B, Wang R, Silver-Brace T, Fishbaugher M, Kennedy M, Finney OC, Chaturvedi R, Marcsisin SR, Hobbs CV, Warner-Lubin M, Talley AK, Wong-Madden S, Stuart K, Wald A, Kappe SH, Kublin JG, Duffy PE.","Clin Infect Dis. 2020 Sep 12;71(6):1481-1490. doi: 10.1093/cid/ciz1010.","Healy SA","Clin Infect Dis","2020","2019/10/18","PMC7486848","","10.1093/cid/ciz1010"
"30585505","Exploring Ethical Concerns About Human Challenge Studies: A Qualitative Study of Controlled Human Malaria Infection Study Participants' Motivations and Attitudes","Kraft SA, Duenas DM, Kublin JG, Shipman KJ, Murphy SC, Shah SK.","J Empir Res Hum Res Ethics. 2019 Feb;14(1):49-60. doi: 10.1177/1556264618820219. Epub 2018 Dec 26.","Kraft SA","J Empir Res Hum Res Ethics","2019","2018/12/27","","","10.1177/1556264618820219"
"24857015","The immune space: a concept and template for rationalizing vaccine development","Manrique A, Adams E, Barouch DH, Fast P, Graham BS, Kim JH, Kublin JG, McCluskey M, Pantaleo G, Robinson HL, Russell N, Snow W, Johnston MI.","AIDS Res Hum Retroviruses. 2014 Nov;30(11):1017-22. doi: 10.1089/AID.2014.0040. Epub 2014 Jun 26.","Manrique A","AIDS Res Hum Retroviruses","2014","2014/05/27","PMC4208609","","10.1089/AID.2014.0040"
"34543346","Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision","Pal S, Myburgh J, Bansil P, Hann A, Robertson L, Gerth-Guyette E, Ambler G, Bizilj G, Kahn M, Zobrist S, Manis MR, Styke NA, Allan V, Ansbro R, Akingbade T, Bryan A, Murphy SC, Kublin JG, Layton M, Domingo GJ.","PLoS One. 2021 Sep 20;16(9):e0257560. doi: 10.1371/journal.pone.0257560. eCollection 2021.","Pal S","PLoS One","2021","2021/09/20","PMC8452025","","10.1371/journal.pone.0257560"
"34665829","Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment","Andrasik MP, Broder GB, Wallace SE, Chaturvedi R, Michael NL, Bock S, Beyrer C, Oseso L, Aina J, Lucas J, Wilson DR, Kublin JG, Mensah GA.","PLoS One. 2021 Oct 19;16(10):e0258858. doi: 10.1371/journal.pone.0258858. eCollection 2021.","Andrasik MP","PLoS One","2021","2021/10/19","PMC8525736","","10.1371/journal.pone.0258858"
"31017084","Beyond Blood Smears: Qualification of Plasmodium 18S rRNA as a Biomarker for Controlled Human Malaria Infections","Seilie AM, Chang M, Hanron AE, Billman ZP, Stone BC, Zhou K, Olsen TM, Daza G, Ortega J, Cruz KR, Smith N, Healy SA, Neal J, Wallis CK, Shelton L, Mankowski TV, Wong-Madden S, Mikolajczak SA, Vaughan AM, Kappe SHI, Fishbaugher M, Betz W, Kennedy M, Hume JCC, Talley AK, Hoffman SL, Chakravarty S, Sim BKL, Richie TL, Wald A, Plowe CV, Lyke KE, Adams M, Fahle GA, Cowan EP, Duffy PE, Kublin JG, Murphy SC.","Am J Trop Med Hyg. 2019 Jun;100(6):1466-1476. doi: 10.4269/ajtmh.19-0094.","Seilie AM","Am J Trop Med Hyg","2019","2019/04/25","PMC6553913","","10.4269/ajtmh.19-0094"
"25640612","A new model for catalyzing translational science: the early stage investigator mentored research scholar program in HIV vaccines","Adamson BJ, Fuchs JD, Sopher CJ, Flood DM, Johnson RP, Haynes BF, Kublin JG; NIAID HIV Vaccine Trials Network.","Clin Transl Sci. 2015 Apr;8(2):166-8. doi: 10.1111/cts.12249. Epub 2014 Dec 30.","Adamson BJ","Clin Transl Sci","2015","2015/02/03","PMC4785016","NIHMS645121","10.1111/cts.12249"
"22201684","Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine","Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ.","J Clin Invest. 2012 Jan;122(1):359-67. doi: 10.1172/JCI60202. Epub 2011 Dec 27.","Frahm N","J Clin Invest","2012","2011/12/29","PMC3248307","","10.1172/JCI60202"
"24104693","The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants","Volk JE, Hessol NA, Gray GE, Kublin JG, Churchyard GJ, Mlisana K, Nchabeleng M, Buchbinder SP, Bekker LG.","Int J STD AIDS. 2014 Apr;25(5):332-40. doi: 10.1177/0956462413506892. Epub 2013 Oct 8.","Volk JE","Int J STD AIDS","2014","2013/10/10","PMC3968181","NIHMS538329","10.1177/0956462413506892"
"33297341","Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP(®) DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults","Edupuganti S, C De Rosa S, Elizaga M, Lu Y, Han X, Huang Y, Swann E, Polakowski L, A Kalams S, Keefer M, Maenza J, C Wise M, Yan J, Morrow MP, Khan AS, Boyer JD, Humeau L, White S, Sardesai NY, Bagarazzi ML, Gilbert PB, Kublin JG, Corey L, Weiner DB, On Behalf Of The Hvtn Study Team, The Niaid-Funded Hiv Vaccine Trials Network.","Vaccines (Basel). 2020 Dec 7;8(4):741. doi: 10.3390/vaccines8040741.","Edupuganti S","Vaccines (Basel)","2020","2020/12/10","PMC7762306","","10.3390/vaccines8040741"
"29218117","Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L.","Stat Commun Infect Dis. 2017 Jan;9(1):20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6.","Gilbert PB","Stat Commun Infect Dis","2017","2017/12/09","PMC5714515","NIHMS898295","10.1515/scid-2016-0001"
"37265668","Plasmodium 18S Ribosomal RNA Biomarker Clearance After Food and Drug Administration-Approved Antimalarial Treatment in Controlled Human Malaria Infection Trials","Chavtur C, Staubus WJ, Ho M, Hergott DEB, Seilie AM, Healy S, Duffy P, Jackson L, Talley A, Kappe SHI, Hoffman SL, Richie TL, Kublin JG, Chang M, Murphy SC.","Open Forum Infect Dis. 2023 Apr 13;10(5):ofad202. doi: 10.1093/ofid/ofad202. eCollection 2023 May.","Chavtur C","Open Forum Infect Dis","2023","2023/06/02","PMC10230565","","10.1093/ofid/ofad202"
"36348617","Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study","Stieh DJ, Barouch DH, Comeaux C, Sarnecki M, Stephenson KE, Walsh SR, Sawant S, Heptinstall J, Tomaras GD, Kublin JG, McElrath MJ, Cohen KW, De Rosa SC, Alter G, Ferrari G, Montefiori D, Mann P, Nijs S, Callewaert K, Goepfert PA, Edupuganti S, Karita E, Seaman MS, Corey L, Baden LR, Pau MG, Schuitemaker H, Tomaka F; ASCENT/HVTN118/HPX2003 Study Team.","J Infect Dis. 2023 Apr 18;227(8):939-950. doi: 10.1093/infdis/jiac445.","Stieh DJ","J Infect Dis","2023","2022/11/09","PMC10202119","","10.1093/infdis/jiac445"
"34048504","PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection","Murphy SC, Deye GA, Sim BKL, Galbiati S, Kennedy JK, Cohen KW, Chakravarty S, Kc N, Abebe Y, James ER, Kublin JG, Hoffman SL, Richie TL, Jackson LA.","PLoS Pathog. 2021 May 28;17(5):e1009594. doi: 10.1371/journal.ppat.1009594. eCollection 2021 May.","Murphy SC","PLoS Pathog","2021","2021/05/28","PMC8191919","","10.1371/journal.ppat.1009594"
"31900486","Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein","Hosseinipour MC, Innes C, Naidoo S, Mann P, Hutter J, Ramjee G, Sebe M, Maganga L, Herce ME, deCamp AC, Marshall K, Dintwe O, Andersen-Nissen E, Tomaras GD, Mkhize N, Morris L, Jensen R, Miner MD, Pantaleo G, Ding S, Van Der Meeren O, Barnett SW, McElrath MJ, Corey L, Kublin JG; HVTN 111 Protocol Team.","Clin Infect Dis. 2021 Jan 23;72(1):50-60. doi: 10.1093/cid/ciz1239.","Hosseinipour MC","Clin Infect Dis","2021","2020/01/05","PMC7823071","","10.1093/cid/ciz1239"
"34871308","Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study","Karuna S, Li SS, Grant S, Walsh SR, Frank I, Casapia M, Trahey M, Hyrien O, Fisher L, Miner MD, Randhawa AK, Polakowski L, Kublin JG, Corey L, Montefiori D; HVTN 405/HPTN 1901 Study Team.","PLoS Med. 2021 Dec 6;18(12):e1003868. doi: 10.1371/journal.pmed.1003868. eCollection 2021 Dec.","Karuna S","PLoS Med","2021","2021/12/06","PMC8687542","","10.1371/journal.pmed.1003868"
"25122028","Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists","Sopher CJ, Adamson BJ, Andrasik MP, Flood DM, Wakefield SF, Stoff DM, Cook RS, Kublin JG, Fuchs JD.","Am J Public Health. 2015 Apr;105(4):823-30. doi: 10.2105/AJPH.2014.302076. Epub 2014 Aug 14.","Sopher CJ","Am J Public Health","2015","2014/08/15","PMC4358212","","10.2105/AJPH.2014.302076"
"23196933","Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?","Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM Jr, Wasserheit JN; HIV Viral Load Working Group.","AIDS. 2013 Mar 27;27(6):981-989. doi: 10.1097/QAD.0b013e32835cb927.","Abu-Raddad LJ","AIDS","2013","2012/12/01","PMC3725236","NIHMS487763","10.1097/QAD.0b013e32835cb927"
"17158329","Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa","Abu-Raddad LJ, Patnaik P, Kublin JG.","Science. 2006 Dec 8;314(5805):1603-6. doi: 10.1126/science.1132338.","Abu-Raddad LJ","Science","2006","2006/12/13","","","10.1126/science.1132338"
"26332672","Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials","Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, Corey L, Mascola JR, Graham BS, Sobieszczyk ME, Kublin JG, Robertson M, Hammer SM, Gray GE, Buchbinder SP, Gilbert PB.","PLoS One. 2015 Sep 2;10(9):e0136626. doi: 10.1371/journal.pone.0136626. eCollection 2015.","Huang Y","PLoS One","2015","2015/09/03","PMC4558095","","10.1371/journal.pone.0136626"
"31095007","Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)","Lemos MP, Lazarus E, Isaacs A, Dietrich J, Morgan C, Huang Y, Grove D, Andrasik M, Laher F, Hural J, Chung E, Dragavon J, Puren A, Gulati RK, Coombs R, McElrath MJ, Gray G, Kublin JG.","J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):e39-e48. doi: 10.1097/QAI.0000000000002015.","Lemos MP","J Acquir Immune Defic Syndr","2019","2019/05/17","PMC6743720","NIHMS1522010","10.1097/QAI.0000000000002015"
"32324753","A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa","Dietrich JJ, Hornschuh S, Khunwane M, Makhale LM, Otwombe K, Morgan C, Huang Y, Lemos M, Lazarus E, Kublin JG, Gray GE, Laher F, Andrasik M; HVTN 915 team.","PLoS One. 2020 Apr 23;15(4):e0231086. doi: 10.1371/journal.pone.0231086. eCollection 2020.","Dietrich JJ","PLoS One","2020","2020/04/24","PMC7179867","","10.1371/journal.pone.0231086"
"15499534","Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites","Bates SJ, Winstanley PA, Watkins WM, Alloueche A, Bwika J, Happi TC, Kremsner PG, Kublin JG, Premji Z, Sibley CH.","J Infect Dis. 2004 Nov 15;190(10):1783-92. doi: 10.1086/425078. Epub 2004 Oct 18.","Bates SJ","J Infect Dis","2004","2004/10/23","","","10.1086/425078"
"29216395","A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation","Murphy SC, Duke ER, Shipman KJ, Jensen RL, Fong Y, Ferguson S, Janes HE, Gillespie K, Seilie AM, Hanron AE, Rinn L, Fishbaugher M, VonGoedert T, Fritzen E, Kappe SH, Chang M, Sousa JC, Marcsisin SR, Chalon S, Duparc S, Kerr N, Möhrle JJ, Andenmatten N, Rueckle T, Kublin JG.","J Infect Dis. 2018 Feb 14;217(5):693-702. doi: 10.1093/infdis/jix613.","Murphy SC","J Infect Dis","2018","2017/12/08","PMC5853383","","10.1093/infdis/jix613"
"32382714","A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa","Bekker LG, Dintwe O, Fiore-Gartland A, Middelkoop K, Hutter J, Williams A, Randhawa AK, Ruhwald M, Kromann I, Andersen PL, DiazGranados CA, Rutkowski KT, Tait D, Miner MD, Andersen-Nissen E, De Rosa SC, Seaton KE, Tomaras GD, McElrath MJ, Ginsberg A, Kublin JG; HVTN 602/Aeras A-042 Protocol Team.","EClinicalMedicine. 2020 Mar 18;21:100313. doi: 10.1016/j.eclinm.2020.100313. eCollection 2020 Apr.","Bekker LG","EClinicalMedicine","2020","2020/05/09","PMC7201034","","10.1016/j.eclinm.2020.100313"
"16127028","Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children","Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ.","Antimicrob Agents Chemother. 2005 Sep;49(9):3601-6. doi: 10.1128/AAC.49.9.3601-3606.2005.","Dzinjalamala FK","Antimicrob Agents Chemother","2005","2005/08/30","PMC1195435","","10.1128/AAC.49.9.3601-3606.2005"
"23859840","Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: a qualitative study exploring HVTN staff perspectives","Andrasik MP, Karuna ST, Nebergall M, Koblin BA, Kublin JG; NIAID HIV Vaccine Trials Network.","Vaccine. 2013 Sep 13;31(40):4398-405. doi: 10.1016/j.vaccine.2013.07.003. Epub 2013 Jul 13.","Andrasik MP","Vaccine","2013","2013/07/18","PMC3894148","NIHMS504127","10.1016/j.vaccine.2013.07.003"
"29898870","Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial","Bekker LG, Moodie Z, Grunenberg N, Laher F, Tomaras GD, Cohen KW, Allen M, Malahleha M, Mngadi K, Daniels B, Innes C, Bentley C, Frahm N, Morris DE, Morris L, Mkhize NN, Montefiori DC, Sarzotti-Kelsoe M, Grant S, Yu C, Mehra VL, Pensiero MN, Phogat S, DiazGranados CA, Barnett SW, Kanesa-Thasan N, Koutsoukos M, Michael NL, Robb ML, Kublin JG, Gilbert PB, Corey L, Gray GE, McElrath MJ; HVTN 100 Protocol Team.","Lancet HIV. 2018 Jul;5(7):e366-e378. doi: 10.1016/S2352-3018(18)30071-7. Epub 2018 Jun 18.","Bekker LG","Lancet HIV","2018","2018/06/15","PMC6028742","","10.1016/S2352-3018(18)30071-7"
"12792863","Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi","Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimdé AA, Kouriba B, Taylor TE, Plowe CV.","J Infect Dis. 2003 Jun 15;187(12):1870-5. doi: 10.1086/375419. Epub 2003 May 21.","Kublin JG","J Infect Dis","2003","2003/06/07","","","10.1086/375419"
"17092820","P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates","Plowe CV, Kublin JG, Doumbo OK.","Drug Resist Updat. 1998;1(6):389-96. doi: 10.1016/s1368-7646(98)80014-9.","Plowe CV","Drug Resist Updat","1998","2006/11/10","","","10.1016/s1368-7646(98)80014-9"
"11807721","Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria","Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV.","J Infect Dis. 2002 Feb 1;185(3):380-8. doi: 10.1086/338566. Epub 2002 Jan 17.","Kublin JG","J Infect Dis","2002","2002/01/25","","","10.1086/338566"
"12234881","Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa","Beare NA, Kublin JG, Lewis DK, Schijffelen MJ, Peters RP, Joaki G, Kumwenda J, Zijlstra EE.","Br J Ophthalmol. 2002 Oct;86(10):1076-9. doi: 10.1136/bjo.86.10.1076.","Beare NA","Br J Ophthalmol","2002","2002/09/18","PMC1771301","","10.1136/bjo.86.10.1076"
"19929694","Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens","Asmuth DM, Brown EL, DiNubile MJ, Sun X, del Rio C, Harro C, Keefer MC, Kublin JG, Dubey SA, Kierstead LS, Casimiro DR, Shiver JW, Robertson MN, Quirk EK, Mehrotra DV.","J Infect Dis. 2010 Jan 1;201(1):132-41. doi: 10.1086/648591.","Asmuth DM","J Infect Dis","2010","2009/11/26","","","10.1086/648591"
"27528946","Ocular disease in patients with TB and HIV presenting with fever in Malawi","Beare N, Kublin JG, Lewis DK, Schijffelen MJ, Peters R, Joaki G, Kumwenda K, Zijlstra EE.","Malawi Med J. 2003;15(1):6-8. doi: 10.4314/mmj.v15i1.10769.","Beare N","Malawi Med J","2003","2016/08/17","PMC3345422","","10.4314/mmj.v15i1.10769"
"27528958","Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre","Lewis DK, Peters R, Schijffelen MJ, Joaki G, Walsh AL, Kublin JG, Kumwenda J, Kampondeni S, Molyneux ME, Zijlstra EE.","Malawi Med J. 2003 Jun;15(2):56-60. doi: 10.4314/mmj.v15i2.10778.","Lewis DK","Malawi Med J","2003","2016/08/17","PMC3345446","","10.4314/mmj.v15i2.10778"
"11906775","Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites","Kublin JG, Lowitt MH, Hamilton RG, Oliveira GA, Nardin EH, Nussenzweig RS, Schmeckpeper BJ, Diggs CL, Bodison SA, Edelman R.","Vaccine. 2002 Mar 15;20(13-14):1853-61. doi: 10.1016/s0264-410x(02)00037-3.","Kublin JG","Vaccine","2002","2002/03/22","","","10.1016/s0264-410x(02)00037-3"
"21533229","Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans","Pine SO, Kublin JG, Hammer SM, Borgerding J, Huang Y, Casimiro DR, McElrath MJ.","PLoS One. 2011 Apr 13;6(4):e18526. doi: 10.1371/journal.pone.0018526.","Pine SO","PLoS One","2011","2011/05/03","PMC3076372","","10.1371/journal.pone.0018526"
"12546114","Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi","Lewis DK, Peters RP, Schijffelen MJ, Joaki GR, Walsh AL, Kublin JG, Kumwenda J, Kampondeni S, Molyneux ME, Zijlstra EE.","Int J Tuberc Lung Dis. 2002 Dec;6(12):1067-74.","Lewis DK","Int J Tuberc Lung Dis","2002","2003/01/28","","",""
"23840043","Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, Fuchs J, Koblin B, Kim DH, Joseph P, Keefer MC, Baden LR, Eldridge J, Boyer J, Sherwat A, Cardinali M, Allen M, Pensiero M, Butler C, Khan AS, Yan J, Sardesai NY, Kublin JG, Weiner DB; NIAID HIV Vaccine Trials Network.","J Infect Dis. 2013 Sep 1;208(5):818-29. doi: 10.1093/infdis/jit236. Epub 2013 Jul 8.","Kalams SA","J Infect Dis","2013","2013/07/11","PMC3733506","","10.1093/infdis/jit236"
"11589941","Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine","Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV.","Lancet. 2001 Sep 29;358(9287):1066-7. doi: 10.1016/S0140-6736(01)06201-8.","Iyer JK","Lancet","2001","2001/10/09","","","10.1016/S0140-6736(01)06201-8"
"21570355","Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team.","Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11.","Gray GE","Lancet Infect Dis","2011","2011/05/17","PMC3417349","NIHMS357717","10.1016/S1473-3099(11)70098-6"
"15304000","A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management","Peters RP, Zijlstra EE, Schijffelen MJ, Walsh AL, Joaki G, Kumwenda JJ, Kublin JG, Molyneux ME, Lewis DK.","Trop Med Int Health. 2004 Aug;9(8):928-34. doi: 10.1111/j.1365-3156.2004.01288.x.","Peters RP","Trop Med Int Health","2004","2004/08/12","","","10.1111/j.1365-3156.2004.01288.x"
"12886812","Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi","Lewis DK, Callaghan M, Phiri K, Chipwete J, Kublin JG, Borgstein E, Zijlstra EE.","Trans R Soc Trop Med Hyg. 2003 Jan-Feb;97(1):91-6. doi: 10.1016/s0035-9203(03)90035-6.","Lewis DK","Trans R Soc Trop Med Hyg","2003","2003/07/31","","","10.1016/s0035-9203(03)90035-6"
"12450702","Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites","Edelman R, Wasserman SS, Kublin JG, Bodison SA, Nardin EH, Oliveira GA, Ansari S, Diggs CL, Kashala OL, Schmeckpeper BJ, Hamilton RG.","Vaccine. 2002 Dec 13;21(3-4):269-80. doi: 10.1016/s0264-410x(02)00468-1.","Edelman R","Vaccine","2002","2002/11/27","","","10.1016/s0264-410x(02)00468-1"
"37440227","Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials","Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, Gray GE, Grinsztejn B, Kotloff KL, Gay CL, Leav B, Miller J, Hirsch I, Sadoff J, Dunkle LM, Neuzil KM, Corey L, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y; COVID-19 Prevention Network (CoVPN).","JAMA Netw Open. 2023 Jul 3;6(7):e2323349. doi: 10.1001/jamanetworkopen.2023.23349.","Theodore DA","JAMA Netw Open","2023","2023/07/13","PMC10346130","","10.1001/jamanetworkopen.2023.23349"
"15652606","Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study","Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, Pendame R, Taylor TE, Molyneux ME.","Lancet. 2005 Jan 15-21;365(9455):233-40. doi: 10.1016/S0140-6736(05)17743-5.","Kublin JG","Lancet","2005","2005/01/18","","","10.1016/S0140-6736(05)17743-5"
"12387962","Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial","Sulo J, Chimpeni P, Hatcher J, Kublin JG, Plowe CV, Molyneux ME, Marsh K, Taylor TE, Watkins WM, Winstanley PA.","Lancet. 2002 Oct 12;360(9340):1136-43. doi: 10.1016/s0140-6736(02)11198-6.","Sulo J","Lancet","2002","2002/10/22","","","10.1016/s0140-6736(02)11198-6"
"14090996","OPHTHALMODYNAMOMETRY IN THE DIAGNOSIS OF INTRACEREBRAL ORTHOSTATIC HYPOTENSION","HOLLENHORST RW, KUBLIN JG, MILLIKAN CH.","Proc Staff Meet Mayo Clin. 1963 Nov 20;38:532-47.","HOLLENHORST RW","Proc Staff Meet Mayo Clin","1963","1963/11/20","","",""
"16107950","Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi","Patnaik P, Jere CS, Miller WC, Hoffman IF, Wirima J, Pendame R, Meshnick SR, Taylor TE, Molyneux ME, Kublin JG.","J Infect Dis. 2005 Sep 15;192(6):984-91. doi: 10.1086/432730. Epub 2005 Aug 12.","Patnaik P","J Infect Dis","2005","2005/08/19","","","10.1086/432730"
"15183620","Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial","Alloueche A, Bailey W, Barton S, Bwika J, Chimpeni P, Falade CO, Fehintola FA, Horton J, Jaffar S, Kanyok T, Kremsner PG, Kublin JG, Lang T, Missinou MA, Mkandala C, Oduola AM, Premji Z, Robertson L, Sowunmi A, Ward SA, Winstanley PA.","Lancet. 2004 Jun 5;363(9424):1843-8. doi: 10.1016/S0140-6736(04)16350-2.","Alloueche A","Lancet","2004","2004/06/09","","","10.1016/S0140-6736(04)16350-2"
"32442195","Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials","Moodie Z, Walsh SR, Laher F, Maganga L, Herce ME, Naidoo S, Hosseinipour MC, Innes C, Bekker LG, Grunenberg N, Mann P, Yu C, deCamp AC, Miner MD, Yates NL, Heptinstall J, Mkhize NN, Dintwe O, Frahm N, Cohen KW, Allen M, Hutter J, Wagner R, Pantaleo G, McElrath MJ, Tomaras GD, Morris L, Montefiori DC, Andersen-Nissen E, Gray GE, Gilbert PB, Kublin JG; NIAID HVTN 100 and HVTN 111 trial teams.","PLoS Med. 2020 May 22;17(5):e1003117. doi: 10.1371/journal.pmed.1003117. eCollection 2020 May.","Moodie Z","PLoS Med","2020","2020/05/23","PMC7244095","","10.1371/journal.pmed.1003117"
"31601541","Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial","Pantaleo G, Janes H, Karuna S, Grant S, Ouedraogo GL, Allen M, Tomaras GD, Frahm N, Montefiori DC, Ferrari G, Ding S, Lee C, Robb ML, Esteban M, Wagner R, Bart PA, Rettby N, McElrath MJ, Gilbert PB, Kublin JG, Corey L; NIAID HIV Vaccine Trials Network.","Lancet HIV. 2019 Nov;6(11):e737-e749. doi: 10.1016/S2352-3018(19)30262-0. Epub 2019 Oct 7.","Pantaleo G","Lancet HIV","2019","2019/10/12","PMC7156919","","10.1016/S2352-3018(19)30262-0"
"32092060","Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines","Laher F, Moodie Z, Cohen KW, Grunenberg N, Bekker LG, Allen M, Frahm N, Yates NL, Morris L, Malahleha M, Mngadi K, Daniels B, Innes C, Saunders K, Grant S, Yu C, Gilbert PB, Phogat S, DiazGranados CA, Koutsoukos M, Van Der Meeren O, Bentley C, Mkhize NN, Pensiero MN, Mehra VL, Kublin JG, Corey L, Montefiori DC, Gray GE, McElrath MJ, Tomaras GD.","PLoS Med. 2020 Feb 24;17(2):e1003038. doi: 10.1371/journal.pmed.1003038. eCollection 2020 Feb.","Laher F","PLoS Med","2020","2020/02/25","PMC7039414","","10.1371/journal.pmed.1003038"
"15772319","Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria","Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ.","Am J Trop Med Hyg. 2005 Mar;72(3):267-72.","Dzinjalamala FK","Am J Trop Med Hyg","2005","2005/03/18","","",""
"10950805","Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis","Doumbo OK, Kayentao K, Djimde A, Cortese JF, Diourte Y, Konaré A, Kublin JG, Plowe CV.","J Infect Dis. 2000 Sep;182(3):993-6. doi: 10.1086/315787. Epub 2000 Aug 17.","Doumbo OK","J Infect Dis","2000","2000/08/19","","","10.1086/315787"
"14757706","Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study","Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, Chimpeni P, Molyneux ME, Taylor TE.","BMJ. 2004 Mar 6;328(7439):545. doi: 10.1136/bmj.37977.653750.EE. Epub 2004 Feb 2.","Plowe CV","BMJ","2004","2004/02/06","PMC381042","","10.1136/bmj.37977.653750.EE"
"24384634","Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'","Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM Jr, Wasserheit JN.","AIDS. 2013 Nov 13;27(17):2826-7. doi: 10.1097/QAD.0000000000000002.","Abu-Raddad LJ","AIDS","2013","2014/01/04","","","10.1097/QAD.0000000000000002"
"1480381","Treatment of progressive Descemet's membrane detachment","Kublin JG.","Ophthalmic Surg. 1992 Sep;23(9):641; author reply 642.","Kublin JG","Ophthalmic Surg","1992","1992/09/01","","",""
"27528930","Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi","Lewis DK, Callaghan M, Phiri K, Chipwete J, Kublin JG, Borgstein E, Zijlstra EE.","Malawi Med J. 2002 Sep;14(2):5-9. doi: 10.4314/mmj.v14i2.10758.","Lewis DK","Malawi Med J","2002","2016/08/17","PMC3346001","","10.4314/mmj.v14i2.10758"
